Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Chandy
Ashok Chandy, Fenton, MI US
| Patent application number | Description | Published |
|---|---|---|
| 20090236920 | SYSTEMS AND METHODS INVOLVING OPITMIZED MOTORS - A motor comprising, a rotor having a shaped pole operative to minimize cogging torque and electro motive Force (EMF) harmonics, a stator having teeth members, the teeth members including, end portions, wherein the end portions partially define slot openings having a first dimension, and a notch opening defined by the end portions having a second dimension. | 09-24-2009 |
| 20100147619 | METHODS AND SYSTEMS INVOLVING ELECTROMAGNETIC TORSION BARS - An actuator assembly including, a polar assembly including an inner tooth and an outer tooth, and a magnet disposed between the inner tooth and the outer tooth, the magnet operative to interact with the polar assembly to induce an electromagnetic torsion bar operative to impart a torque on a first shaft connected to the ring magnet. | 06-17-2010 |
George Chandy, Laguna Beach, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20080319310 | Imaging Agents For Monitoring Changes Of Dopamine Receptors And Methods Of Using Thereof - The present invention is related generally to a method for screening subjects to determine those subjects more likely to develop diabetes by quantization of insulin producing cells. The present invention is also related to the diagnosis of diabetes and related to monitor disease progression or treatment efficacy of candidate drugs. | 12-25-2008 |
George K. Chandy, Laguna Beach, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20080221024 | Analogs of Shk Toxin and Their Uses in Selective Inhibittion of Kv1. 3 Potassium Channels - Analogs of ShK toxin and methods for using such ShK analogs. The ShK analogs generally comprise ShK toxin attached to a chemical entity (e.g. an atom, molecule, group, residue, compound, moiety, etc.) that has an anionic charge. In some embodiments the chemical entity attached to the ShK toxin may comprise an amino acid residue. The ShK analogs may be administered to human or non-human animal subjects to cause inhibition of potassium channels or to otherwise treat diseases or disorders. In some embodiments, the chemical entity to which the ShK toxin is attached may be chosen to provide selective inhibition of certain potassium channels (e.g., Kv1.3 channels) over other potassium channels (e.g., Kv1.1 channels). In come embodiments, the chemical entity to which the ShK toxin is attached may include a fluorophore, thereby providing a fluorophore tagged ShK analog. Such fluorophore tagged ShK analogs may be used in flow cytometry alone, or in conjunction with class II tetramers that can detect autoreactive cells. | 09-11-2008 |
| 20090306159 | Inhibition of Intermediate-Conductance Calcium Activated Potassium Channels in the Treatment and/or Prevention of Atherosclerosis - Methods for treating or preventing atherosclerosis in human or non-human animal subjects by inhibiting or blocking intermediate-conductance calcium activated potassium channels associated with vascular smooth muscle and/or other cells which play a role in the pathogenesis of atherosclerosis (e.g., KCa3.1, KCNN4, IKCa1, IK1, SK4 channels). | 12-10-2009 |
K. George Chandy, Laguna Beach, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20090048270 | Compounds, Methods And Devices for Inhibiting Neoproliferative Changes in Blood Vessel Walls - Methods, compositions and devices for inhibiting neoproliferative changes in blood vessel walls or other anatomical structures. One or more compounds of Formula I or I-A set forth herein are administered systemically and/or locally to human or veterinary patients to deter or prevent unwanted proliferative changes in blood vessels or other anatomical structures. The invention may be used to deter or prevent stenosis or restenosis of arteries following angioplasty and/or stent placement. In one embodiment, there is provided an implantable stent or stent graft from which one or more compounds of the present invention will elute or otherwise be delivered into an affected blood vessel wall. | 02-19-2009 |
Mathew A. Chandy, Bangalore IN
| Patent application number | Description | Published |
|---|---|---|
| 20100249884 | Medical Device and Method for Operating the Same - In the case of a medical device with several electronic components, a possibility must be provided for enabling the components to be rapidly matched to each other, in order to guarantee the functional correctness of the medical device. In particular in the case when, for example, an item of operating software is modified for one individual component only, it can occur that this component no longer interoperates with the other components in a desired way. In this context, at a particular point in time, for each of the electronic components of a apparatus data for the component is copied and the copied data is stored outside the storage facility of the component, making it possible at a later point in time, which can be defined, for the copied data for each component to be stored in its storage facility. | 09-30-2010 |